<DOC>
	<DOCNO>NCT02890303</DOCNO>
	<brief_summary>This study evaluate outcome subject elect Zepto capsulotomies cataract surgery phacoemulsification .</brief_summary>
	<brief_title>A Prospective Multi-Center Study Anterior Lens Capsulotomy Using Mynosys Zepto System</brief_title>
	<detailed_description>This study evaluate outcome subject elect Zepto capsulotomies cataract surgery phacoemulsification evaluate safety effectiveness . The primary effectiveness endpoint complete capsulotomy least 95 percent case . The primary safety endpoint posterior capsular rupture virtuous loss 4 percent less subject . Other parameter capture study include anterior capsule tear , corneal touch , capsulotomy diameter , contraption Zepto capsulotomy , size corneal incision pre post Zepto , interocular lens contraption evaluation zonular stability incidence severity adverse event . The criteria patient success access base successful completion 360 degree capsulotomy without tissue bridge posterior capsule rupture vitreous loss . The criterion study success access base great equal 95 percent case complete 360 degree capsulotomy without tissue bridge le 4 percent subject posterior capsule rupture vitreous loss .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<criteria>1 . Subjects must age 22 old , 2 . Subjects consent undergoing phacoemulsification IOL implant surgery treatment symptomatic age relate lens cataract , elect undergo ZeptoTM capsulotomy , 3 . Subjects must willing able return schedule treatment followup examination 3 month . 1 . Disease pathology treatment eye compromise visual performance refractive outcome ( e.g . previous refractive surgery ) , 2 . Zonular abnormality , 3 . Posterior polar cataract , 4 . Fellow eye acuity less 20/200 , 5 . Any prior ocular surgery study eye , 6 . Pupillary dilation preoperative exam le 7 mm diameter , 7 . Proliferative diabetic retinopathy , 8 . Disorders ocular muscle , nystagmus strabismus , 9 . Chronic uveitis , 10 . Abnormal corneal endothelium , 11 . Subjects medication , opinion surgeon , significant ocular side effect , 12 . Pregnant nursing ( lactate ) woman , 13 . Implanted ocular device drug study eye , 14 . Any condition , judgment investigator would prevent subject complete study ( e.g . document diagnosis treatment symptom associate dementia , mental illness ) , 15 . Current participation another drug device clinical study , participation clinical study within six month .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>